everlywell.comHealthcare / Digital HealthFounded: 2015Funding to Date: $674.09MM
Everyly Health created a new kind of healthcare experience that’s centered around people. Their infrastructure guides the full testing experience with the support of a national clinician network that’s composed of hundreds of physicians, nurses, genetic counselors, PharmDs, and member care specialists. This company was founded by Julia Cheek in 2015 and is headquartered in Austin, TX.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/27/2021 | Series F | $154.68MM | $xx.xx | $3.5B | Prysm Capital, Touchdown Ventures | |
Price per Share
$xx.xx
Shares Outstanding
2,400,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Prysm Capital, Touchdown Ventures
|
||||||
03/23/2021 | Series E | $192.92MM | $xx.xx | $2.69B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,768,393
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/03/2020 | Series D | $258.1MM | $xx.xx | $1.32B | Blackrock, Foresite Capital, Greenspring Associates, Highland Capital Partners, Morningside Ventures, Portfolio, The Chernin Group | |
Price per Share
$xx.xx
Shares Outstanding
9,879,426
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blackrock, Foresite Capital, Greenspring Associates, Highland Capital Partners, Morningside Ventures, Portfolio, The Chernin Group
|
||||||
02/21/2020 | Series C | $25MM | $xx.xx | $226.76MM | Goodwater Capital, Next Coast Ventures, Nextgen Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,032,450
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Goodwater Capital, Next Coast Ventures, Nextgen Venture Partners
|
||||||
04/16/2019 | Series B | $29.63MM | $xx.xx | $154.74MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,884,140
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/28/2017 | Series A-1 | $1.46MM | $xx.xx | $37.76MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,523,561
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/28/2017 | Series A | $9.16MM | $xx.xx | $37.76MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,083,005
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/19/2016 | Series Seed | $3.14MM | $xx.xx | $8.98MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,174,804
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|